Welcome to B2BAGE
Plant extracts Naringin factory
Plant extracts Naringin factory

Minimum Order: 0
Quality/Safety Certification: 0.00


Product Name Naringin
Molecular Formula C27H32O14
Molecular Weight 580.53
CAS NO 10236-47-6
Appearance Miro-yellow powd

Plant extracts Naringin factory

Product NameNaringin 
Latin NameNaringin
Molecular FormulaC27H32O14
Molecular Weight580.53
CAS NO10236-47-6
AppearanceMiro-yellow powder
Product Content≥98% 
Analytical MethodHPLC
  
Product Origin

Citrus Paradisi Macfadyen

  
Action and UsesStudies have shown that naringin interferes with enzymatic activity in the intestines and, thus, with the breakdown of certain drugs, resulting in higher blood levels of the drug. A number of drugs that are known to be affected by the naringin in grapefruit include calcium channel blockers, estrogen, sedatives, medications for high blood pressure, allergies, AIDS, and cholesterol-lowering drugs. Caffeine levels and effects of caffeine may also be extended by consuming grapefruit or grapefruit juice. While the effect of naringin on the metabolism of a drug can increase the drug's effectiveness, it can also result in dosages that are inadvertently too high. Therefore, it's best not to take any drugs with grapefruit juice unless the interaction with the drug is known..
  
Analysis 
 Product contentNaringin≥98%
Sieve analysis100% pass 80 mesh
Loss on Drying≤1.0%
Residue on Ignition≤1.0%
Heavy Metal<20ppm
As<2ppm
Residual SolventsEur.Pharm.2000
  
Microbiology 
 Total Plate Count<1000cfu/g
Yeast & Mold<100cfu/g
E.ColiNegative
SalmonellaNegative
   
ConclusionConform with specification
  
StorageStore in sealed containers at cool & dry place. Protect from light, moisture and pest infestation
  
Shelf life2 year when properly stored
 

 

Ads by Google



About Us | Contact Us | Help | Terms & Conditions
Hot Products: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9
Copyright Notice @ 2008-2022 B2BAGE Limited and/or its subsidiaries and licensors. All rights reserved.